IP Library › Assignment 068347/0450
Patent Assignment
Reel/Frame 068347/0450

Merger

Recorded: 2024-08-20 Pages: 5
Assignor
VALO EARLY DISCOVERY, INC.
Executed: 2021-09-01
Assignee
VALO HEALTH, INC.
399 BOYLSTON STREET, BOSTON, MASSACHUSETTS, 02116
Covered Property (1)
Carboxamides as Ubiquitin-Specific Protease Inhibitors
Application: 17/266,026 →
Publication: US 2021/0323975
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger Sep 8, 2021
From: VALO EARLY DISCOVERY, INC.
To: VALO HEALTH, INC.
Reel/Frame 057438/0025 →
Release of Security Interest Oct 17, 2023
From: FIRST-CITIZENS BANK & TRUST COMPANY, AS AGENT
To: VALO HEALTH, INC.; VALO HEALTH, LLC
Reel/Frame 065255/0660 →
Assignment of Assignor's Interest Aug 20, 2024
From: GUERIN, DAVID J.; NG, PUI YEE; WANG, ZHONGGUO; SHELEKHIN, TATIANA
To: FORMA THERAPEUTICS, INC.
Reel/Frame 068340/0737 →
Assignment of Assignor's Interest Aug 20, 2024
From: FORMA THERAPEUTICS, INC.
To: INTEGRAL EARLY DISCOVERY, INC.
Reel/Frame 068719/0190 →
Change of Name Aug 20, 2024
From: INTEGRAL EARLY DISCOVERY, INC.
To: VALO EARLY DISCOVERY, INC.
Reel/Frame 068725/0912 →